222 related articles for article (PubMed ID: 34022909)
1. pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer.
Wang H; Shi W; Zeng D; Huang Q; Xie J; Wen H; Li J; Yu X; Qin L; Zhou Y
J Nanobiotechnology; 2021 May; 19(1):152. PubMed ID: 34022909
[TBL] [Abstract][Full Text] [Related]
2. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.
Wang H; Zhang F; Wen H; Shi W; Huang Q; Huang Y; Xie J; Li P; Chen J; Qin L; Zhou Y
J Nanobiotechnology; 2020 Jan; 18(1):8. PubMed ID: 31918714
[TBL] [Abstract][Full Text] [Related]
3. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells.
Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H
J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722
[TBL] [Abstract][Full Text] [Related]
4. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
[TBL] [Abstract][Full Text] [Related]
5. Redox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors.
Lin J; Zhao C; Liu C; Fu S; Han L; Lu X; Yang C
Int J Nanomedicine; 2018; 13():805-830. PubMed ID: 29445276
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells.
Gote V; Sharma AD; Pal D
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513992
[TBL] [Abstract][Full Text] [Related]
7. Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria.
Tian Y; Zhang H; Qin Y; Li D; Liu Y; Wang H; Gan L
Drug Dev Ind Pharm; 2018 Dec; 44(12):2071-2082. PubMed ID: 30112929
[TBL] [Abstract][Full Text] [Related]
8. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
9. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.
Chen FQ; Zhang JM; Fang XF; Yu H; Liu YL; Li H; Wang YT; Chen MW
Acta Pharmacol Sin; 2017 Jun; 38(6):859-873. PubMed ID: 28260803
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.
Tian X; Bera H; Guo X; Xu R; Sun J; He Z; Cun D; Yang M
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56858-56872. PubMed ID: 34806372
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
Zhang W; Shi Y; Chen Y; Yu S; Hao J; Luo J; Sha X; Fang X
Eur J Pharm Biopharm; 2010 Aug; 75(3):341-53. PubMed ID: 20451605
[TBL] [Abstract][Full Text] [Related]
12. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.
Zhao D; Zhang H; Yang S; He W; Luan Y
Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
Shen J; Yin Q; Chen L; Zhang Z; Li Y
Biomaterials; 2012 Nov; 33(33):8613-24. PubMed ID: 22910221
[TBL] [Abstract][Full Text] [Related]
14. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
15. Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy.
Chen D; Ge S; Zuo L; Wang S; Liu M; Li S
Drug Deliv; 2020 Dec; 27(1):1094-1105. PubMed ID: 32706289
[TBL] [Abstract][Full Text] [Related]
16. Reduction-Triggered Paclitaxel Release Nano-Hybrid System Based on Core-Crosslinked Polymer Dots with a pH-Responsive Shell-Cleavable Colorimetric Biosensor.
Kim SG; Ryplida B; Phuong PTM; Won HJ; Lee G; Bhang SH; Park SY
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661903
[TBL] [Abstract][Full Text] [Related]
17. ATP Suppression by pH-Activated Mitochondria-Targeted Delivery of Nitric Oxide Nanoplatform for Drug Resistance Reversal and Metastasis Inhibition.
Deng Y; Jia F; Chen X; Jin Q; Ji J
Small; 2020 Jun; 16(23):e2001747. PubMed ID: 32378343
[TBL] [Abstract][Full Text] [Related]
18. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer.
Zhou J; Zhao WY; Ma X; Ju RJ; Li XY; Li N; Sun MG; Shi JF; Zhang CX; Lu WL
Biomaterials; 2013 May; 34(14):3626-38. PubMed ID: 23422592
[TBL] [Abstract][Full Text] [Related]
19. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable polyurethane micelles with pH and reduction responsive properties for intracellular drug delivery.
Guan Y; Su Y; Zhao L; Meng F; Wang Q; Yao Y; Luo J
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1221-1230. PubMed ID: 28415410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
